These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 10794303

  • 1. Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line--derived neurotrophic factor in patients with Parkinson's disease. Report of two cases and technical considerations.
    Mendez I, Dagher A, Hong M, Hebb A, Gaudet P, Law A, Weerasinghe S, King D, Desrosiers J, Darvesh S, Acorn T, Robertson H.
    J Neurosurg; 2000 May; 92(5):863-9. PubMed ID: 10794303
    [Abstract] [Full Text] [Related]

  • 2. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts.
    Rosenblad C, Martinez-Serrano A, Björklund A.
    Neuroscience; 1996 Dec; 75(4):979-85. PubMed ID: 8938733
    [Abstract] [Full Text] [Related]

  • 3. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease.
    Kordower JH, Freeman TB, Snow BJ, Vingerhoets FJ, Mufson EJ, Sanberg PR, Hauser RA, Smith DA, Nauert GM, Perl DP.
    N Engl J Med; 1995 Apr 27; 332(17):1118-24. PubMed ID: 7700284
    [Abstract] [Full Text] [Related]

  • 4. Glial cell line-derived neurotrophic factor-supplemented hibernation of fetal ventral mesencephalic neurons for transplantation in Parkinson disease: long-term storage.
    Hebb AO, Hebb K, Ramachandran AC, Mendez I.
    J Neurosurg; 2003 May 27; 98(5):1078-83. PubMed ID: 12744369
    [Abstract] [Full Text] [Related]

  • 5. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease.
    Kordower JH, Freeman TB, Chen EY, Mufson EJ, Sanberg PR, Hauser RA, Snow B, Olanow CW.
    Mov Disord; 1998 May 27; 13(3):383-93. PubMed ID: 9613726
    [Abstract] [Full Text] [Related]

  • 6. Additive effect of glial cell line-derived neurotrophic factor and neurotrophin-4/5 on rat fetal nigral explant cultures.
    Meyer M, Matarredona ER, Seiler RW, Zimmer J, Widmer HR.
    Neuroscience; 2001 May 27; 108(2):273-84. PubMed ID: 11734360
    [Abstract] [Full Text] [Related]

  • 7. Promotion of survival and regeneration of nigral dopamine neurons in a rat model of Parkinson's disease after implantation of embryonal carcinoma-derived neurons genetically engineered to produce glial cell line-derived neurotrophic factor.
    Nakao N, Yokote H, Nakai K, Itakura T.
    J Neurosurg; 2000 Apr 27; 92(4):659-70. PubMed ID: 10761657
    [Abstract] [Full Text] [Related]

  • 8. Grafting of nigral tissue hibernated with tirilazad mesylate and glial cell line-derived neurotrophic factor.
    Petersen A, Hansson O, Emgård M, Brundin P.
    Cell Transplant; 2000 Apr 27; 9(5):577-84. PubMed ID: 11144955
    [Abstract] [Full Text] [Related]

  • 9. Enhancement of graft survival and sensorimotor behavioral recovery in rats undergoing transplantation with dopaminergic cells exposed to glial cell line-derived neurotrophic factor.
    Mehta V, Hong M, Spears J, Mendez I.
    J Neurosurg; 1998 Jun 27; 88(6):1088-95. PubMed ID: 9609305
    [Abstract] [Full Text] [Related]

  • 10. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue.
    Yurek DM.
    Exp Neurol; 1998 Oct 27; 153(2):195-202. PubMed ID: 9784279
    [Abstract] [Full Text] [Related]

  • 11. Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants.
    Sawle GV, Bloomfield PM, Björklund A, Brooks DJ, Brundin P, Leenders KL, Lindvall O, Marsden CD, Rehncrona S, Widner H.
    Ann Neurol; 1992 Feb 27; 31(2):166-73. PubMed ID: 1575455
    [Abstract] [Full Text] [Related]

  • 12. Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases.
    Mendez I, Dagher A, Hong M, Gaudet P, Weerasinghe S, McAlister V, King D, Desrosiers J, Darvesh S, Acorn T, Robertson H.
    J Neurosurg; 2002 Mar 27; 96(3):589-96. PubMed ID: 11883846
    [Abstract] [Full Text] [Related]

  • 13. Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease.
    McLeod M, Hong M, Mukhida K, Sadi D, Ulalia R, Mendez I.
    Eur J Neurosci; 2006 Jul 27; 24(2):361-70. PubMed ID: 16903847
    [Abstract] [Full Text] [Related]

  • 14. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.
    Cunningham LA, Su C.
    Exp Neurol; 2002 Apr 27; 174(2):230-42. PubMed ID: 11922664
    [Abstract] [Full Text] [Related]

  • 15. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease.
    Hauser RA, Freeman TB, Snow BJ, Nauert M, Gauger L, Kordower JH, Olanow CW.
    Arch Neurol; 1999 Feb 27; 56(2):179-87. PubMed ID: 10025423
    [Abstract] [Full Text] [Related]

  • 16. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
    Winkler C, Georgievska B, Carlsson T, Lacar B, Kirik D.
    Neuroscience; 2006 Aug 11; 141(1):521-31. PubMed ID: 16697115
    [Abstract] [Full Text] [Related]

  • 17. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.
    Mendez I, Sanchez-Pernaute R, Cooper O, Viñuela A, Ferrari D, Björklund L, Dagher A, Isacson O.
    Brain; 2005 Jul 11; 128(Pt 7):1498-510. PubMed ID: 15872020
    [Abstract] [Full Text] [Related]

  • 18. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease.
    Lindvall O, Sawle G, Widner H, Rothwell JC, Björklund A, Brooks D, Brundin P, Frackowiak R, Marsden CD, Odin P.
    Ann Neurol; 1994 Feb 11; 35(2):172-80. PubMed ID: 8109898
    [Abstract] [Full Text] [Related]

  • 19. Survival of dopaminergic neurons in fetal-tissue grafts.
    Hoffer BJ, van Horne C.
    N Engl J Med; 1995 Apr 27; 332(17):1163-4. PubMed ID: 7700292
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.